» Articles » PMID: 25538636

A Clinical Review of the Treatment of Catatonia

Overview
Specialty Psychiatry
Date 2014 Dec 25
PMID 25538636
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Catatonia is a severe motor syndrome with an estimated prevalence among psychiatric inpatients of about 10%. At times, it is life-threatening especially in its malignant form when complicated by fever and autonomic disturbances. Catatonia can accompany many different psychiatric illnesses and somatic diseases. In order to recognize the catatonic syndrome, apart from thorough and repeated observation, a clinical examination is needed. A screening instrument, such as the Bush-Francis Catatonia Rating Scale, can guide the clinician through the neuropsychiatric examination. Although severe and life-threatening, catatonia has a good prognosis. Research on the treatment of catatonia is scarce, but there is overwhelming clinical evidence of the efficacy of benzodiazepines, such as lorazepam, and electroconvulsive therapy.

Citing Articles

Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence.

Mora F, Gomez Sanchez-Lafuente C, De Iceta M, Roset C, Cardenas A, Perez D Front Psychiatry. 2025; 15:1506142.

PMID: 40013022 PMC: 11862477. DOI: 10.3389/fpsyt.2024.1506142.


Catatonia in a psychiatric setup having diverse etiology: A case series.

Yalgi R, Dere S, Ponda A, Kaur D, Ghildiyal R Ind Psychiatry J. 2025; 33(2):406-408.

PMID: 39898087 PMC: 11784688. DOI: 10.4103/ipj.ipj_252_24.


Complete Resolution of Catatonia Following a Single Intravenous Lorazepam Challenge Test: An Early Intervention in Psychosis Case Report.

Okoro C, Homer K, Kelbrick M, Walker J, Sam M, Burge J Psychopharmacol Bull. 2025; 55(1):70-75.

PMID: 39744407 PMC: 11626920.


The Use of Zolpidem in Catatonia: A Case Report.

Yakubu A, Gibson S, Smit R Cureus. 2024; 16(11):e73493.

PMID: 39669822 PMC: 11635180. DOI: 10.7759/cureus.73493.


A Comprehensive Review and Update on Cannabis Hyperemesis Syndrome.

Loganathan P, Gajendran M, Goyal H Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598458 PMC: 11597608. DOI: 10.3390/ph17111549.


References
1.
Rooseleer J, Willaert A, Sienaert P . [Rating scales for assessing catatonia; which ones are the best?]. Tijdschr Psychiatr. 2011; 53(5):287-98. View

2.
Suzuki K, Awata S, Takano T, Ebina Y, Shindo T, Harada N . Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone. Psychiatry Clin Neurosci. 2006; 60(4):486-92. DOI: 10.1111/j.1440-1819.2006.01536.x. View

3.
Obregon D, Velasco R, Wuerz T, Catalano M, Catalano G, Kahn D . Memantine and catatonia: a case report and literature review. J Psychiatr Pract. 2011; 17(4):292-9. DOI: 10.1097/01.pra.0000400268.60537.5e. View

4.
McEvoy J . Relief from catatonic immobility can be maintained. J Clin Psychopharmacol. 1986; 6(2):126-7. View

5.
Sienaert P, Rooseleer J, De Fruyt J . Measuring catatonia: a systematic review of rating scales. J Affect Disord. 2011; 135(1-3):1-9. DOI: 10.1016/j.jad.2011.02.012. View